Provided by Tiger Trade Technology Pte. Ltd.

Rocket Pharmaceuticals, Inc.

3.78
+0.25007.08%
Post-market: 3.76-0.0200-0.53%16:41 EDT
Volume:2.20M
Turnover:8.23M
Market Cap:414.95M
PE:-22.24
High:3.81
Open:3.54
Low:3.54
Close:3.53
52wk High:5.45
52wk Low:2.53
Shares:109.77M
Float Shares:84.96M
Volume Ratio:2.00
T/O Rate:2.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1700
EPS(LYR):-2.0100
ROE:-4.77%
ROA:-28.42%
PB:1.13
PE(LYR):-1.88

Loading ...

Sep 12, 2023

Major Issues Report

Form 8-K - Current report
Aug 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 24, 2023

Major Issues Report

Form 8-K - Current report
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 05, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 21, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 13, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 11, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 06, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 05, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 04, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 10, 2023

Major Issues Report

8-K - Current report